Sol-Gel Technologies Ltd. Ordinary Shares (SLGL)

Price$70.00

Favorite Metrics

Price vs S&P 500 (26W)80.71%

Price vs S&P 500 (4W)-8.26%

Market Capitalization$228.83M

All Metrics

P/CF (Annual)710.65x

Book Value / Share (Quarterly)$8.19

P/TBV (Annual)0.92x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)70.96%

Cash Flow / Share (Quarterly)$0.10

Price vs S&P 500 (YTD)71.16%

Net Profit Margin (TTM)-31.60%

EPS (TTM)$-2.20

10-Day Avg Trading Volume0.08M

EPS Excl Extra (TTM)$-2.20

Revenue Growth (5Y)17.19%

EPS (Annual)$-2.20

ROI (Annual)-26.86%

Net Profit Margin (5Y Avg)-450.06%

Cash / Share (Quarterly)$8.61

Revenue Growth QoQ (YoY)150.36%

ROA (Last FY)-20.48%

Revenue Growth TTM (YoY)68.04%

EBITD / Share (TTM)$-2.67

ROE (5Y Avg)-32.71%

Operating Margin (TTM)-38.88%

Cash Flow / Share (Annual)$0.10

P/B Ratio10.03x

P/B Ratio (Quarterly)5.15x

Net Income / Employee (Annual)$-0

EV / Revenue (TTM)11.23x

Net Interest Coverage (TTM)-1037.50x

ROA (TTM)-18.73%

EV / EBITDA (TTM)46.74x

EPS Incl Extra (Annual)$-2.20

Current Ratio (Annual)4.37x

Quick Ratio (Quarterly)4.21x

3-Month Avg Trading Volume0.03M

52-Week Price Return1377.40%

EV / Free Cash Flow (Annual)791.99x

Revenue / Employee (TTM)$1

Tangible BV / Share (Quarterly)$1.74

P/S Ratio (Annual)11.80x

Asset Turnover (Annual)0.65x

52-Week High$97.97

Operating Margin (5Y Avg)-487.58%

EPS Excl Extra (Annual)$-2.20

CapEx CAGR (5Y)-36.35%

26-Week Price Return89.46%

Quick Ratio (Annual)4.21x

13-Week Price Return8.97%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)4.37x

Enterprise Value$217.796

Revenue / Share Growth (5Y)78.08%

Asset Turnover (TTM)0.59x

Book Value / Share Growth (5Y)26.85%

Revenue / Employee (Annual)$1

Pretax Margin (Annual)-31.60%

Cash / Share (Annual)$8.61

3-Month Return Std Dev109.63%

Net Income / Employee (TTM)$-0

ROE (Last FY)-26.86%

EPS Basic Excl Extra (Annual)$-2.20

Receivables Turnover (TTM)6.97x

EV / Free Cash Flow (TTM)791.99x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-2.20

Receivables Turnover (Annual)6.97x

ROI (TTM)-24.29%

P/S Ratio (TTM)11.80x

Pretax Margin (5Y Avg)-450.06%

Revenue / Share (Annual)$6.96

Tangible BV / Share (Annual)$1.83

Price vs S&P 500 (52W)1342.31%

Year-to-Date Return75.30%

5-Day Price Return-0.73%

EPS Normalized (Annual)$-2.20

ROA (5Y Avg)-27.50%

Net Profit Margin (Annual)-31.60%

Month-to-Date Return-6.75%

EBITD / Share (Annual)$-2.67

Operating Margin (Annual)-38.88%

P/CF (TTM)710.65x

ROI (5Y Avg)-32.71%

EPS Basic Excl Extra (TTM)$-2.20

P/TBV (Quarterly)0.80x

P/B Ratio (Annual)5.15x

Pretax Margin (TTM)-31.60%

Book Value / Share (Annual)$8.19

Price vs S&P 500 (13W)6.10%

Beta1.22x

P/FCF (Annual)832.11x

Revenue / Share (TTM)$6.96

ROE (TTM)-24.29%

52-Week Low$4.11

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

4.14

Industry Peers — Pharmaceuticals(308)

Symbol	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
SLGLSol-Gel Technologies Ltd. Ordinary Shares	11.80x	68.04%	—	—	$70.00
LLYEli Lilly & Co.	13.45x	44.70%	83.04%	27.59%	$919.90
JNJJohnson & Johnson	5.82x	7.87%	67.95%	14.90%	$230.69
ABBVABBVIE INC.	5.97x	8.57%	71.62%	-2.88%	$203.71
MRKMerck & Co., Inc.	4.51x	1.31%	78.55%	21.23%	$117.10
AZNAstraZeneca PLC	5.39x	8.63%	81.31%	21.88%	$200.69
NVSNovartis AG	4.87x	8.91%	75.82%	15.26%	$150.99
NVONovo-Nordisk A/S	3.74x	6.43%	80.98%	20.66%	$40.46
ABTAbbott Laboratories	3.71x	6.59%	56.50%	8.20%	$96.00
PFEPfizer Inc.	2.50x	-1.64%	75.81%	-3.51%	$27.52
BMYBristol-Myers Squibb Co.	2.52x	-0.22%	72.63%	—	$59.13

About

Sol-Gel Technologies develops branded and generic topical pharmaceuticals for dermatology, with a focus on rare skin diseases. Its lead asset, SGT-610 (Patidegib Gel 2%), is a hedgehog pathway blocker targeting basal cell carcinoma prevention in Gorlin syndrome. The company also develops SGT-210 for rare keratosis-related indications such as Darier Disease, PC, PPK, and Olmsted.